癌診断用の画像装置:グローバル市場分析と予測...市場調査レポートについてご紹介

【英文タイトル】MediPoint: Breast Cancer Imaging - Global Analysis and Market Forecasts

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 15
1.2 List of Figures 20
2 Introduction 24
2.1 Catalyst 25
3 Disease Overview 26
3.1 Anatomy & Physiology of the Breast 26
3.2 Pathophysiology of Breast Cancer 27
3.3 Detection of Breast Cancer 27
3.4 Types of Breast Cancer 28
3.5 Clinical Presentation 30
3.6 Clinical Outcomes 31
3.6.1 Assessment Procedure 31
3.6.2 Screening Guidelines 34
3.7 Epidemiology of Breast Cancer 37
3.8 Economic Impact of Breast Cancer Imaging 40
4 Imaging Techniques 41
4.1 Mammography 41
4.1.1 Overview 41
4.1.2 Types of Mammography 43
4.2 Non-Mammographic Techniques 48
4.2.1 Breast Ultrasound Imaging 48
4.2.2 Breast Magnetic Resonance Imaging 49
4.3 Comparison of Mammography, Ultrasound, and MRI 50
4.4 Alternative Breast Imaging Techniques 51
4.4.1 Nuclear Imaging Techniques 52
4.4.2 Computed Tomography 53
4.4.3 Optical Breast Imaging 54
4.4.4 Electric Impedance-Based Techniques 54
4.4.5 Thermography 55
4.4.6 Elastography 55
4.4.7 Ductogram 55
5 Competitive Assessment 56
5.1 Overview 56
5.2 Film Screen Mammography 57
5.2.1 Performa (GE Healthcare) 57
5.2.2 Alpha RT/Alpha ST (GE Healthcare) 60
5.2.3 MAMMOMAT 1000 (Siemens Healthcare) 63
5.2.4 MAMMOMAT 3000 Nova (Siemens Healthcare) 65
5.2.5 M-IV/M-IV Platinum (Hologic) 67
5.2.6 MammoDiagnost (Philips Healthcare) 69
5.2.7 Planmed Nuance Classic (Planmed) 71
5.2.8 Planmed Sophie Classic (Planmed) 73
5.2.9 Analog Giotto Image (Internazionale Medico Scientifica) 74
5.2.10 HAWK-2M (Hologic) 76
5.2.11 MGU-1000A (Toshiba Medical Systems) 78
5.3 CR Mammography 79
5.3.1 Fuji Computed Radiography Mammography Suite (FCRMS) (Fujifilm Medical Systems) 79
5.3.2 KODAK DirectView (Carestream Health) 82
5.3.3 Xpress CR System (Konica Minolta) 83
5.3.4 REGIUS PureView (Konica Minolta) 85
5.3.5 Agfa CR Mammography Systems (DX-M, CR 30-Xm, and CR 85-X) (Agfa Healthcare) 86
5.4 Full-Field Digital Mammography 88
5.4.1 Selenia Dimensions (Hologic) 88
5.4.2 Selenia (Hologic) 91
5.4.3 Selenia S (Hologic) 93
5.4.4 Selenia Performance (Hologic) 94
5.4.5 Senographe DS (GE Healthcare) 96
5.4.6 Senographe Essential (GE Healthcare) 97
5.4.7 Senographe Care (GE Healthcare) 100
5.4.8 SenoBright CESM (GE Healthcare) 101
5.4.9 MAMMOMAT Inspiration (Siemens Healthcare) 103
5.4.10 Aspire HD (US)/Amulet (Outside the US) (Fujifilm) 105
5.4.11 MammoDiagnost DR (Philips Healthcare) 108
5.4.12 MicroDose (Philips Healthcare) 110
5.4.13 Giotto Image 3D/3DL (Internazionale Medico Scientifica) 112
5.4.14 Planmed Nuance/Nuance Excel (Planmed) 114
5.4.15 Fairy DR (Allengers Medical Systems) 116
5.4.16 Serenity 117
5.5 3D Mammography 118
5.5.1 Selenia Dimensions 3D System (Hologic) 118
5.5.2 True 3D Breast Tomosynthesis (Siemens Healthcare) 120
5.5.3 Giotto Tomo (Internazionale Medico Scientifica) 122
5.5.4 FUJIFILM 3Dimensional Mammography (Fujifilm) 124
5.6 Breast Ultrasound Imaging 126
5.6.1 somo.v Automated Breast Ultrasound (ABUS) (GE Healthcare) 126
5.6.2 SonoCine AWBUS (SonoCine) 128
5.6.3 ACUSON S2000 ABVS (Siemens Healthcare) 129
5.6.4 Terason t3200 Ultrasound System Breast Series (Terason Ultrasound) 131
5.7 Breast MRI 132
5.7.1 Aurora 1.5T Dedicated Breast MRI System (Aurora Imaging Technology) 132
5.8 Other Breast Imaging Techniques 134
5.8.1 PEM Flex Solo II (Naviscan) 134
5.8.2 Computerized Tomography Laser Mammography (CTLM) Model 1020 (Imaging Diagnostic Systems) 136
5.8.3 Dilon 6800/Dilon 6800 Acella (Dilon Diagnostics) 138
5.8.4 LumaGEM (Gamma Medica) 140
5.8.5 Discovery NM 750b (GE Healthcare) 142
6 Unmet Needs 145
6.1 Lower Radiation Dose 145
6.2 Increase Patient Comfort 146
6.3 Reduce False-Positives and False-Negatives 148
6.4 Loss of Sensitivity of Mammography in Dense Breasts 150
6.5 Unreliable Mammograms in Surgically-Operated Breasts and Breasts with Implants 152
6.6 Commitment to Training 153
7 Pipeline Products 155
7.1 Breast Cancer Imaging Pipeline Products Overview 155
7.2 GE Breast Tomosynthesis 156
7.2.1 Overview 156
7.2.2 SWOT Analysis 157
7.3 MAMMOMAT Inspiration PRIME Edition 158
7.3.1 Overview 158
7.3.2 SWOT Analysis 158
7.4 MicroDose SI 159
7.4.1 Overview 159
7.4.2 SWOT Analysis 159
7.5 Selenia Dimensions 2D Contrast-Enhanced Digital Mammography (CEDM) 160
7.5.1 Overview 160
7.5.2 SWOT Analysis 160
7.6 SenoCase 160
7.6.1 Overview 160
7.6.2 SWOT Analysis 161
7.7 Electrical Mammogram 162
7.7.1 Overview 162
7.7.2 SWOT Analysis 162
8 Industry Overview 163
8.1 Purchasing Cycle 163
8.1.1 Product Life Cycle 163
8.1.2 Cost Effectiveness in Screening Settings 165
8.1.3 Cost-Effectiveness in Diagnostic Settings 165
8.2 Market Access 166
8.2.1 Purchasing Decisions 166
8.2.2 Regulatory Process 166
8.3 Quality Assurance 169
8.3.1 US 169
8.3.2 EU 169
8.3.3 Brazil 170
8.3.4 Japan 170
8.3.5 China and India 170
8.4 Adoption of New Technologies 171
8.4.1 Influence of Clinical Trials Results 171
8.4.2 Reimbursement 172
8.4.3 Economic Resources 172
8.4.4 Low Breast Cancer Incidence and Absence of a National Screening Program 172
8.4.5 Competitive Advantage 173
8.5 Current Reimbursement Trends 174
8.5.1 US 174
8.5.2 Europe 175
8.5.3 France 176
8.5.4 Germany 176
8.5.5 Italy 176
8.5.6 Spain 176
8.5.7 UK 177
8.5.8 30TJapan 177
8.5.9 Brazil 177
8.5.10 30TChina 178
8.5.11 30TIndia 178
8.6 Trends in Detector Technology for Digital Mammography 179
8.7 Evolving Scatter-Removal Mechanisms 183
8.8 Overdiagnosis 185
8.9 Malpractice Litigations 186
8.10 Mergers and Acquisitions/Key Partnerships 187
8.10.1 GE Healthcare Acquires U-Systems 187
8.10.2 Koninklijke Philips Electronics Acquires MicroDose Mammography from Sectra 187
8.10.3 Hologic Acquires Beijing Healthcome Technology 187
8.10.4 Hologic Acquires Sentinelle Medica 188
8.10.5 Koninklijke Philips Electronics Acquires Shanghai Apex Electronics Technology 188
8.10.6 Fujifilm Medical Systems acquired FUJIFILM-RU 188
8.10.7 Other Key Events 189
9 Current and Future Players 190
9.1 Overview 190
9.2 Trends in Corporate Strategy 191
9.3 Company Profiles 192
9.3.1 GE Healthcare 192
9.3.2 Hologic 194
9.3.3 Siemens 196
9.3.4 Koninklijke Philips Electronics 197
9.3.5 Fujifilm Medical Systems 199
9.3.6 Internazionale Medico Scientifica (IMS) 200
9.3.7 Planmed 201
9.3.8 Konica Minolta Medical Imaging 202
9.3.9 Agfa Healthcare 203
9.3.10 Carestream Health 204
9.3.11 SonoCine 205
9.3.12 Aurora Imaging Technology 206
9.3.13 Imaging Diagnostic Systems 207
9.3.14 Naviscan 208
9.3.15 Dilon Diagnostics 209
9.3.16 Gamma Medica 209
9.3.17 Allengers Medical Systems 210
10 Market Drivers & Opportunities 211
10.1 Market Drivers 211
10.1.1 Increase in the Incidence of Breast Cancer 211
10.1.2 Increased Awareness of the Benefits of Screening 211
10.1.3 Increased Breast Cancer Incidence Due to an Aging Population 212
10.1.4 FDA Reclassification of Mammography Equipment 212
10.1.5 New Technologies to Drive Market Growth 212
10.1.6 Changes in Age Inclusion Criteria in Breast Cancer Screening Programs 214
10.1.7 Adoption of Digital Mammography Units Worldwide 214
10.2 Opportunities 217
10.2.1 Emerging Economies Promise Future Growth 217
10.2.2 Invest in Emerging Technologies 218
10.2.3 Product Improvement 219
10.3 Market Barriers 219
10.3.1 Shortage of Dedicated Mammography Professionals 219
10.3.2 Reduced Hospital Budgets 220
10.3.3 Refurbished Equipment Sales 221
10.3.4 Reimbursement 221
10.3.5 Substitutes 222
11 Country Outlooks & Forecasts 223
11.1 Major Markets Overview 223
11.2 United States 226
11.2.1 United States Market Analysis 226
11.3 France 230
11.3.1 France Market Analysis 230
11.4 Germany 231
11.4.1 Germany Market Analysis 231
11.5 Italy 232
11.5.1 Italy Market Analysis 232
11.6 Spain 233
11.6.1 Spain Market Analysis 233
11.7 United Kingdom 234
11.7.1 United Kingdom Market Analysis 234
11.8 Japan 235
11.8.1 Japan Market Analysis 235
11.9 Brazil 237
11.9.1 Brazil Market Analysis 237
11.10 China 238
11.10.1 China Market Analysis 238
11.11 India 239
11.11.1 India Market Analysis 239
12 Appendix 241
12.1 Bibliography 241
12.2 Abbreviations 271
12.3 Report Methodology 276
12.3.1 Overview 276
12.3.2 Coverage 276
12.3.3 Secondary Research 276
12.3.4 Forecast Methodology 277
12.4 Physicians and Specialists Included in this Study 278
12.5 Primary Research 279
12.6 Physician Survey 279
12.7 About the Authors 280
12.7.1 Analysts 280
12.7.2 Global Head of Healthcare 281
12.8 Definitions 282
12.9 About MediPoint 282
12.10 About GlobalData 282
12.11 Contact Us 283
12.12 Disclaimer 283


【レポート販売概要】

■ タイトル:癌診断用の画像装置:グローバル市場分析と予測
■ 英文:MediPoint: Breast Cancer Imaging - Global Analysis and Market Forecasts
■ 発行日:2013年5月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403161055
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。